Emerging evidence underscores the centrality of FA metabolism perturbations in driving disease progression, from hyperuricemia-triggered crystal deposition to sustained NLRP3 inflammasome activation, ultimately forming a self-perpetuating “metabolism-immunity” axis. The gene discussed is NLRP3; the disease is hyperuricemia.